Ankyra Therapeutics, Inc. announced it raised $14.5 Million in an initial filing from an offering of $14.5 Million

Company

Location

About

Ankyra Therapeutics is a biotechnology company that has developed a highly differentiated technology platform that expands the therapeutic window of therapeutic drugs by forming a stable depot after local administration leading to prolonged immune activation and potent local and systemic immunity with reduced systemic toxicity. Ankyra is headquartered in Cambridge, Massachusetts.